Table 2.

Multiple stepwise linear regression of risk factors of target organ damage in the overall studied population.

Variance		B	SE	β	P value	95% CI	VIF
CIMT	Age	0.004	0.000	0.402	<0.001	0.040–0.050	1.060
	Sex	−0.028	0.011	−0.093	0.012	−0.049–0.006	1.109
	HDL-c	−0.039	0.017	−0.083	0.025	−0.074–0.005	1.100
	cSBP	0.001	0.000	0.095	0.009	0.000–0.001	1.061
LVMI	Age	0.404	0.086	0.194	<0.001	0.235–0.573	1.545
	Sex	−8.411	2.045	−0.149	<0.001	−12.426–4.396	1.183
	BMI	0.568	0.253	0.085	0.025	0.072–1.064	1.300
	Antihypertensive drugs (yes or no)	5.106	1.885	0.097	0.007	1.406–8.807	1.158
	HDL-c	−5.964	2.719	−0.076	0.029	−11.303–0.626	1.097
	HR	−0.373	0.093	−0.137	<0.001	−0.557–0.19	1.067
	cSBP	0.156	0.058	0.105	0.008	0.042–0.271	1.396
	cf-PWV	1.775	0.589	0.137	0.003	0.618–2.931	1.876
eGFR	Age	−0.555	0.042	−0.428	<0.001	−0.638–0.473	1.246
	Sex	−5.460	1.408	−0.161	<0.001	−8.224–2.697	2.055
	Height	−0.176	0.083	−0.090	0.034	−0.338–0.014	2.148
	FBG	0.792	0.273	0.087	0.004	0.257–1.328	1.074
	LDL-c	−2.326	0.584	−0.117	<0.001	−3.473–1.179	1.034
	HR	0.174	0.052	0.110	0.001	0.073–0.276	1.279
	cDBP	−0.136	0.041	−0.103	0.001	−0.216–0.055	1.176
	cAIx@HR75	0.100	0.042	0.080	0.017	0.018–0.183	1.349
Log ACR	Age	0.003	0.001	0.110	0.010	0.001–0.005	1.060
	FBG	0.017	0.008	0.094	0.028	0.002–0.033	1.054
	cSBP	0.004	0.001	0.186	<0.001	0.002–0.006	1.023

All variables adjusted for age, sex (male or female), height, BMI, body mass index, smoking history, antihypertensive drugs (yes or no), HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; FBG, fasting blood glucose; pMAP, peripheral mean arterial pressure; HR, heart rate beats per minute; VIF, variance inflation factor.

The bold values represent the values that are statistically significant (P < 0.05).